Hazzard & Hore  is a litigation boutique that was founded in 1993 by Scott Hazzard and Ed Hore. The firm’s practice areas include commercial and employment law, and intellectual property law with a proven track record in pharmaceutical litigation.

Our clients include financial institutions, major domestic and foreign corporations, pharmaceutical manufacturers, trade organizations, and small to medium size businesses. Our lawyers have experience representing clients in the pharmaceutical industry, including proceedings under the Patented Medicines (Notice of Compliance) Regulations, and have appeared at all levels of the Ontario and Federal Court, including the Supreme Court of Canada.
 
News & Events
On November 14, 2006, the Canadian Generic Pharmaceutical Association ("CGPA") launched a legal challenge to the October 2006 amendments to the Food and Drug Regulations passed by the federal government.  more »
Justice Hughes dismissed Abbott's application under the Patented Medicines (Notice of Compliance) Regulations for an order prohibiting the Minister of Health from issuing Sandoz a Notice of Compliance for its clarithromycin product until after the expiry of Canadian Patent No. 2,386,527 (the "527 Patent").  more »
The Supreme Court of Canada dismissed Apotex's appeal from an Order prohibiting the Minister of Health from issuing a Notice of Compliance to Apotex in respect of its clopidogrel bisulfate drug.  more »
Biovail commenced a notice of application seeking to prohibit the Minister of Health from issuing a Notice of Compliance (“NOC”) to Sandoz for its bupropion hydrochloride sustained release formulation.  more »
In unanimous reasons released November 3, 2006, the Supreme Court of Canada overturned the Federal Court of Appeal, and restored the lower court’s decision that the Minister of Health was correct to issue a Notice of Compliance to Apotex for its omeprazole magnesium capsules.  more »